S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
S&P 500   3,750.77
DOW   30,303.17
QQQ   319.43
Log in

Khiron Life Sciences Stock Forecast, Price & News

-0.02 (-5.58 %)
(As of 01/27/2021 03:57 PM ET)
Today's Range
Now: $0.29
50-Day Range
MA: $0.29
52-Week Range
Now: $0.29
Volume1.09 million shs
Average Volume513,334 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Khiron Life Sciences Corp. operates as an integrated cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin. Khiron Life Sciences Corp. was founded in 2017 and is based in Vancouver, Canada.


Overall MarketRank

1.44 out of 5 stars

Medical Sector

499th out of 1,926 stocks

Drug Manufacturers - Specialty & Generic Industry

6th out of 61 stocks

Analyst Opinion: 3.5Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable
-0.02 (-5.58 %)
(As of 01/27/2021 03:57 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KHRNF News and Ratings via Email

Sign-up to receive the latest news and ratings for KHRNF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Khiron Life Sciences (OTCMKTS:KHRNF) Frequently Asked Questions

How has Khiron Life Sciences' stock price been impacted by Coronavirus?

Khiron Life Sciences' stock was trading at $0.4259 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, KHRNF shares have decreased by 31.7% and is now trading at $0.2911.
View which stocks have been most impacted by COVID-19

Is Khiron Life Sciences a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Khiron Life Sciences in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Khiron Life Sciences stock.
View analyst ratings for Khiron Life Sciences
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Khiron Life Sciences?

Wall Street analysts have given Khiron Life Sciences a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Khiron Life Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for KHRNF?

1 brokerages have issued 12-month price objectives for Khiron Life Sciences' stock. Their forecasts range from $2.80 to $2.80. On average, they expect Khiron Life Sciences' share price to reach $2.80 in the next twelve months. This suggests a possible upside of 861.9% from the stock's current price.
View analysts' price targets for Khiron Life Sciences
or view Wall Street analyst' top-rated stocks.

Are investors shorting Khiron Life Sciences?

Khiron Life Sciences saw a decline in short interest during the month of December. As of December 31st, there was short interest totaling 128,000 shares, a decline of 46.4% from the December 15th total of 238,900 shares. Based on an average daily volume of 948,900 shares, the short-interest ratio is currently 0.1 days.
View Khiron Life Sciences' Short Interest

Who are some of Khiron Life Sciences' key competitors?

Who are Khiron Life Sciences' key executives?

Khiron Life Sciences' management team includes the following people:
  • Mr. Alvaro Francisco Torres, Co-Founder, CEO & Director (Age 41)
  • Mr. Vicente Fox, Strategic Advisor & Director (Age 77)
  • Mr. Andres Galofre, Co-Founder & VP of Bus. Devel.s (Age 38)
  • Mr. Joel Friedman, Chief Financial Officer
  • Mr. Manuel Buendia, VP of Operations
  • Mr. Matt Murphy, VP of Compliance (Age 58)
  • Ms. Livia M. Maduri, Gen. Counsel & Corp. Sec.
  • Jon Packer, VP of Communications
  • Mr. Luis Chavez, Country Mang. of Mexico
  • Mr. Marco Algorta, Country Mang. of Uruguay

What is Khiron Life Sciences' stock symbol?

Khiron Life Sciences trades on the OTCMKTS under the ticker symbol "KHRNF."

How do I buy shares of Khiron Life Sciences?

Shares of KHRNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Khiron Life Sciences' stock price today?

One share of KHRNF stock can currently be purchased for approximately $0.29.

What is Khiron Life Sciences' official website?

The official website for Khiron Life Sciences is www.khiron.ca.

How can I contact Khiron Life Sciences?

The company can be reached via phone at 705-527-3564.

This page was last updated on 1/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.